Artwork

Content provided by Pri-Med. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pri-Med or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

New Benefits Give SGLT2 Inhibitors Their Turn to Shine - Frankly Speaking Ep 376

8:15
 
Share
 

Manage episode 412552907 series 1338191
Content provided by Pri-Med. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pri-Med or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376

Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.

Episode resource links:

  • DM/HF: Age Ageing 2024 Jan 2;53(1):afad254. doi: 10.1093/ageing/afad254
  • Kidney stones: JAMA Intern Med. 2024 Jan 29:e237660. doi: 10.1001/jamainternmed.2023.7660

Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato

  continue reading

402 episodes

Artwork
iconShare
 
Manage episode 412552907 series 1338191
Content provided by Pri-Med. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pri-Med or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376

Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.

Episode resource links:

  • DM/HF: Age Ageing 2024 Jan 2;53(1):afad254. doi: 10.1093/ageing/afad254
  • Kidney stones: JAMA Intern Med. 2024 Jan 29:e237660. doi: 10.1001/jamainternmed.2023.7660

Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato

  continue reading

402 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide